Advertisement
Screener

IRADIMED CORPORATION (IRMD) Selling and Marketing Expense

2.8 / 5 stars · 68/120 Roast Me

IRADIMED CORPORATION Selling and Marketing Expense

IRADIMED CORPORATION (IRMD) reported Selling and Marketing Expense of $4.25 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:SellingAndMarketingExpense · last filed 2026-07-31

  • IRADIMED CORPORATION selling and marketing expense for the quarter ending 2026-06-30 was $4.25M, a 5.89% increase year-over-year.
  • IRADIMED CORPORATION selling and marketing expense for the quarter ending 2026-03-31 was $4.05M, a 2.97% decline year-over-year.
  • IRADIMED CORPORATION selling and marketing expense for the quarter ending 2025-12-31 was $4.60M, a 1.91% increase year-over-year.
  • IRADIMED CORPORATION selling and marketing expense for the quarter ending 2025-09-30 was $4.63M, a 22.01% increase year-over-year.
  • IRADIMED CORPORATION selling and marketing expense for fiscal 2025 was $17.42M, a 11.55% increase from fiscal 2024.
  • IRADIMED CORPORATION selling and marketing expense for fiscal 2024 was $15.62M, a 28.61% increase from fiscal 2023.
  • IRADIMED CORPORATION selling and marketing expense for fiscal 2023 was $12.14M, a 4.24% decline from fiscal 2022.
  • IRADIMED CORPORATION selling and marketing expense for fiscal 2022 was $12.68M, a 20.12% increase from fiscal 2021.
Period endSelling and Marketing Expense 3 monthSelling and Marketing Expense 3 month as first filedSelling and Marketing Expense 6 monthSelling and Marketing Expense 6 month as first filedSelling and Marketing Expense 9 monthSelling and Marketing Expense 12 monthSelling and Marketing Expense 12 month as first filed
2026-06-30$4.25M
10-Q · filed 2026-07-31
$8.30M
10-Q · filed 2026-07-31
$12.90M
derived: sum of 3 quarters · filed 2026-07-31
$17.53M
derived: sum of 4 quarters · filed 2026-07-31
2026-03-31$4.05M
10-Q · filed 2026-05-01
$8.66M
derived: sum of 2 quarters · filed 2026-05-01
$13.29M
derived: sum of 3 quarters · filed 2026-05-01
$17.30M
derived: sum of 4 quarters · filed 2026-07-31
2025-12-31$4.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06
$9.23M
derived: sum of 2 quarters · filed 2026-03-06
$13.24M
derived: sum of 3 quarters · filed 2026-07-31
$17.42M
10-K · filed 2026-03-06
2025-09-30$4.63M
10-Q · filed 2025-11-03
$8.64M
derived: sum of 2 quarters · filed 2026-07-31
$12.82M
10-Q · filed 2025-11-03
$17.33M
derived: sum of 4 quarters · filed 2026-07-31
2025-06-30$4.01M
10-Q · filed 2026-07-31
$4.01M
10-Q · filed 2025-08-01
$8.19M
10-Q · filed 2026-07-31
$8.19M
10-Q · filed 2025-08-01
$12.70M
derived: sum of 3 quarters · filed 2026-07-31
$16.50M
derived: sum of 4 quarters · filed 2026-07-31
2025-03-31$4.18M
10-Q · filed 2026-05-01
$4.18M
10-Q · filed 2025-05-05
$8.69M
derived: sum of 2 quarters · filed 2026-05-01
$12.49M
derived: sum of 3 quarters · filed 2026-05-01
$15.96M
derived: sum of 4 quarters · filed 2026-05-01
2024-12-31$4.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06
$8.31M
derived: sum of 2 quarters · filed 2026-03-06
$11.79M
derived: sum of 3 quarters · filed 2026-03-06
$15.62M
10-K · filed 2026-03-06
$15.62M
10-K · filed 2025-03-06
2024-09-30$3.80M
10-Q · filed 2025-11-03
$7.27M
derived: sum of 2 quarters · filed 2025-11-03
$11.10M
10-Q · filed 2025-11-03
$14.43M
derived: sum of 4 quarters · filed 2025-11-03
2024-06-30$3.48M
10-Q · filed 2025-08-01
$7.30M
10-Q · filed 2025-08-01
$10.63M
derived: sum of 3 quarters · filed 2025-09-03
$13.50M
derived: sum of 4 quarters · filed 2025-09-03
2024-03-31$3.83M
10-Q · filed 2025-05-05
$821.00K
10-Q · filed 2024-05-02
$7.16M
derived: sum of 2 quarters · filed 2025-09-03
$10.02M
derived: sum of 3 quarters · filed 2025-09-03
$12.97M
derived: sum of 4 quarters · filed 2025-09-03
2023-12-31$3.33M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-03
$6.19M
derived: sum of 2 quarters · filed 2025-09-03
$9.14M
derived: sum of 3 quarters · filed 2025-09-03
$12.14M
10-K/A · filed 2025-09-03
2023-09-30$2.86M
10-Q · filed 2024-10-31
$5.81M
derived: sum of 2 quarters · filed 2024-10-31
$8.81M
10-Q · filed 2024-10-31
$10.27M
derived: sum of 4 quarters · filed 2024-10-31
2023-06-30$2.95M
10-Q · filed 2024-08-01
$5.95M
10-Q · filed 2024-08-01
$7.41M
derived: sum of 3 quarters · filed 2024-08-01
$10.44M
derived: sum of 4 quarters · filed 2024-08-01
2023-03-31$793.72K
10-Q · filed 2024-05-02
$3.00M
10-Q · filed 2023-05-04
$4.46M
derived: sum of 2 quarters · filed 2024-05-02
$7.50M
derived: sum of 3 quarters · filed 2024-05-02
$10.40M
derived: sum of 4 quarters · filed 2024-05-02
2022-12-31$3.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01
$6.70M
derived: sum of 2 quarters · filed 2024-03-01
$9.61M
derived: sum of 3 quarters · filed 2024-03-01
$12.68M
10-K · filed 2024-03-01
2022-09-30$3.04M
10-Q · filed 2023-11-03
$5.94M
derived: sum of 2 quarters · filed 2023-11-03
$9.01M
10-Q · filed 2023-11-03
$12.14M
derived: sum of 4 quarters · filed 2023-11-03
2022-06-30$2.91M
10-Q · filed 2023-08-03
$5.98M
10-Q · filed 2023-08-03
$9.10M
derived: sum of 3 quarters · filed 2023-08-03
$11.68M
derived: sum of 4 quarters · filed 2023-08-03
2022-03-31$3.07M
10-Q · filed 2023-05-04
$6.19M
derived: sum of 2 quarters · filed 2023-05-04
$8.78M
derived: sum of 3 quarters · filed 2023-05-04
$11.25M
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31$3.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
$5.71M
derived: sum of 2 quarters · filed 2023-03-02
$8.18M
derived: sum of 3 quarters · filed 2023-03-02
$10.56M
10-K · filed 2023-03-02
2021-09-30$2.59M
10-Q · filed 2022-11-03
$5.06M
derived: sum of 2 quarters · filed 2022-11-03
$7.43M
10-Q · filed 2022-11-03
$10.50M
derived: sum of 4 quarters · filed 2022-11-03
2021-06-30$2.47M
10-Q · filed 2022-08-05
$4.85M
10-Q · filed 2022-08-05
$7.92M
derived: sum of 3 quarters · filed 2022-08-05
$10.20M
derived: sum of 4 quarters · filed 2022-08-05
2021-03-31$2.38M
10-Q · filed 2022-05-06
$5.45M
derived: sum of 2 quarters · filed 2022-05-06
$7.73M
derived: sum of 3 quarters · filed 2022-05-06
$10.10M
derived: sum of 4 quarters · filed 2022-05-06
2020-12-31$3.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04
$5.35M
derived: sum of 2 quarters · filed 2022-03-04
$7.73M
derived: sum of 3 quarters · filed 2022-03-04
$10.16M
10-K · filed 2022-03-04
2020-09-30$2.28M
10-Q · filed 2021-11-05
$4.66M
derived: sum of 2 quarters · filed 2021-11-05
$7.09M
10-Q · filed 2021-11-05
$9.65M
derived: sum of 4 quarters · filed 2022-03-04
2020-06-30$2.37M
10-Q · filed 2021-08-06
$4.81M
10-Q · filed 2021-08-06
$7.37M
derived: sum of 3 quarters · filed 2022-03-04
$9.67M
derived: sum of 4 quarters · filed 2022-03-04
2020-03-31$2.43M
10-Q · filed 2021-05-07
$5.00M
derived: sum of 2 quarters · filed 2022-03-04
$7.29M
derived: sum of 3 quarters · filed 2022-03-04
$9.49M
derived: sum of 4 quarters · filed 2022-03-04
2019-12-31$2.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04
$4.86M
derived: sum of 2 quarters · filed 2022-03-04
$7.06M
derived: sum of 3 quarters · filed 2022-03-04
$9.17M
10-K · filed 2022-03-04
2019-09-30$2.30M
10-Q · filed 2020-11-06
$4.50M
derived: sum of 2 quarters · filed 2020-11-06
$6.61M
10-Q · filed 2020-11-06
$8.66M
derived: sum of 4 quarters · filed 2021-03-05
2019-06-30$2.20M
10-Q · filed 2020-08-06
$4.31M
10-Q · filed 2020-08-06
$6.36M
derived: sum of 3 quarters · filed 2021-03-05
$8.14M
derived: sum of 4 quarters · filed 2021-03-05
2019-03-31$2.11M
10-Q · filed 2020-05-07
$4.16M
derived: sum of 2 quarters · filed 2021-03-05
$5.94M
derived: sum of 3 quarters · filed 2021-03-05
$7.46M
derived: sum of 4 quarters · filed 2021-03-05
2018-12-31$2.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05
$3.83M
derived: sum of 2 quarters · filed 2021-03-05
$5.35M
derived: sum of 3 quarters · filed 2021-03-05
$7.00M
10-K · filed 2021-03-05
2018-09-30$1.78M
10-Q · filed 2019-11-07
$3.30M
derived: sum of 2 quarters · filed 2019-11-07
$4.95M
10-Q · filed 2019-11-07
$6.51M
derived: sum of 4 quarters · filed 2020-03-06
2018-06-30$1.52M
10-Q · filed 2019-08-07
$3.16M
10-Q · filed 2019-08-07
$4.72M
derived: sum of 3 quarters · filed 2020-03-06
$5.98M
derived: sum of 4 quarters · filed 2020-03-06
2018-03-31$1.65M
10-Q · filed 2019-05-08
$3.21M
derived: sum of 2 quarters · filed 2020-03-06
$4.46M
derived: sum of 3 quarters · filed 2020-03-06
$5.78M
derived: sum of 4 quarters · filed 2020-03-06
2017-12-31$1.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06
$2.81M
derived: sum of 2 quarters · filed 2020-03-06
$4.14M
derived: sum of 3 quarters · filed 2020-03-06
$5.50M
10-K · filed 2020-03-06
2017-09-30$1.25M
10-Q · filed 2018-11-07
$2.58M
derived: sum of 2 quarters · filed 2018-11-07
$3.94M
10-Q · filed 2018-11-07
$5.18M
derived: sum of 4 quarters · filed 2019-03-07
2017-06-30$1.32M
10-Q · filed 2018-08-08
$2.69M
10-Q · filed 2018-08-08
$3.93M
derived: sum of 3 quarters · filed 2019-03-07
$5.27M
derived: sum of 4 quarters · filed 2019-03-07
2017-03-31$1.36M
10-Q · filed 2018-05-08
$2.60M
derived: sum of 2 quarters · filed 2019-03-07
$3.95M
derived: sum of 3 quarters · filed 2019-03-07
$5.36M
derived: sum of 4 quarters · filed 2019-03-07
2016-12-31$1.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
$2.59M
derived: sum of 2 quarters · filed 2019-03-07
$4.00M
derived: sum of 3 quarters · filed 2019-03-07
$5.28M
10-K · filed 2019-03-07
2016-09-30$1.35M
10-Q · filed 2017-11-06
$2.76M
derived: sum of 2 quarters · filed 2017-11-06
$4.04M
10-Q · filed 2017-11-06
$5.35M
derived: sum of 4 quarters · filed 2018-03-08
2016-06-30$1.41M
10-Q · filed 2017-08-04
$2.69M
10-Q · filed 2017-08-04
$4.00M
derived: sum of 3 quarters · filed 2018-03-08
$5.21M
derived: sum of 4 quarters · filed 2018-03-08
2016-03-31$1.28M
10-Q · filed 2017-05-05
$2.59M
derived: sum of 2 quarters · filed 2018-03-08
$3.80M
derived: sum of 3 quarters · filed 2018-03-08
$4.90M
derived: sum of 4 quarters · filed 2018-03-08
2015-12-31$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
$2.51M
derived: sum of 2 quarters · filed 2018-03-08
$3.62M
derived: sum of 3 quarters · filed 2018-03-08
$4.71M
10-K · filed 2018-03-08
2015-09-30$1.21M
10-Q · filed 2016-11-04
$2.31M
derived: sum of 2 quarters · filed 2016-11-04
$3.40M
10-Q · filed 2016-11-04
$4.19M
derived: sum of 4 quarters · filed 2017-03-10
2015-06-30$1.10M
10-Q · filed 2016-08-05
$2.19M
10-Q · filed 2016-08-05
$2.99M
derived: sum of 3 quarters · filed 2017-03-10
$3.87M
derived: sum of 4 quarters · filed 2017-03-10
2015-03-31$1.09M
10-Q · filed 2016-05-06
$1.88M
derived: sum of 2 quarters · filed 2017-03-10
$2.76M
derived: sum of 3 quarters · filed 2017-03-10
$3.63M
derived: sum of 4 quarters · filed 2017-03-10
2014-12-31$792.10K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10
$1.67M
derived: sum of 2 quarters · filed 2017-03-10
$2.54M
derived: sum of 3 quarters · filed 2017-03-10
$3.30M
10-K · filed 2017-03-10
2014-09-30$880.71K
10-Q · filed 2015-11-10
$1.75M
derived: sum of 2 quarters · filed 2015-11-10
$2.51M
10-Q · filed 2015-11-10
$3.22M
derived: sum of 4 quarters · filed 2015-11-10
2014-06-30$864.52K
10-Q · filed 2015-08-11
$1.62M
10-Q · filed 2015-08-11
$2.34M
derived: sum of 3 quarters · filed 2015-08-11
$2.86M
derived: sum of 4 quarters · filed 2015-08-11
2014-03-31$759.79K
10-Q · filed 2015-05-11
$1.48M
derived: sum of 2 quarters · filed 2015-05-11
$1.99M
derived: sum of 3 quarters · filed 2015-05-11
$2.49M
derived: sum of 4 quarters · filed 2015-05-11
2013-12-31$719.19K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23
$1.23M
derived: sum of 2 quarters · filed 2015-03-23
$1.73M
derived: sum of 3 quarters · filed 2015-03-23
$2.30M
10-K · filed 2015-03-23
2013-09-30$513.73K
10-Q · filed 2014-11-13
$1.01M
derived: sum of 2 quarters · filed 2014-11-13
$1.58M
10-Q · filed 2014-11-13
2013-06-30$495.66K
10-Q · filed 2014-08-14
$1.06M
10-Q · filed 2014-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
ARTIVION, INC. (AORT)United States$1.123B-345.09
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02